Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

HF 4

Status in the House for the 91st Legislature (2019 - 2020)

Description

Drug manufacturer or wholesale distributor prohibited from charging unconscionable prices for prescription drugs; Board of Pharmacy, commissioner of human services, and health plan companies required to notify the attorney general of certain prescription drug price increases; attorney general authorized to take action against drug manufacturers and wholesalers related to price increases; civil penalties imposed; and money appropriated.

Authors (35)

Actions

House

01/10/2019
Introduction and first reading, referred to Health and Human Services Policy
pg. 33 Intro
01/14/2019
Author added Mariani
pg. 50
02/07/2019
Committee report, to adopt as amended and re-refer to Commerce
pg. 218a
02/21/2019
Committee report, to adopt as amended and re-refer to Judiciary Finance and Civil Law Division
pg. 416a
03/04/2019
Committee report, to adopt and re-refer to Ways and Means
pg. 702
03/04/2019
04/03/2019
Motion to recall and re-refer, motion did not prevail State Government Finance Division
pg. 1839
02/27/2020
Division action, to adopt as amended and return to Ways and Means
03/11/2020
Committee report, without further rec to amend, re-refer to State Government Finance Division
pg. 6936a
03/26/2020
Committee report, without further rec to amend, re-refer to Ways and Means
pg. 7101